Sartorius Stedim Biotech S.A. (0RG8.IL)
IOB · EUR · Healthcare · Medical Instruments & Supplies
€219.80 (+2.57%) as of
Key statistics
- Market cap
- 25.12B
- P/E (TTM)
- 31.86
- EPS (TTM)
- 6.90
- Dividend yield
- 0.78%
- 52-week range
- 0.00 – 225.00
- Beta
- 0.48
- Revenue (TTM)
- 2.96B
- Profit margin
- 15.56%
About Sartorius Stedim Biotech S.A.
Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; batch and intensified chromatography systems for smaller molecules applications, such as oligonucleotides, peptides, and insulin; and recombinant albumin based solutions. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. It serves manufacturers of medications, foods, and chemicals, as well as research and development laboratories. The company was founded in 1870 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Headquarters
- Aubagne, France
- Employees
- 10,849
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.